SCHEMBL5906801

SCHEMBL5906801

CC(C)(C)OC(=O)N(Cc1ccccc1)c1ccc(-c2ccnc(N[C@@H](Cc3ccccc3)C(=O)O)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 3/20 0.49
NPR3 P17342 3/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GPR142 Q7Z601 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
APP P05067 1/20 0.38
ACE P12821 1/20 0.38
HCRTR1 O43613 1/20 0.37
CAMK2D Q13557 1/20 0.36
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
PAX8 Q06710 1/20 0.36
ITGA4 P13612 1/20 0.36
ITGB7 P26010 1/20 0.36
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5906799 1.00 PDK1 (0.49) PDK1NPR3CYP3A4CYP2C8CYP2C9
SCHEMBL5906901 0.82 ADORA2A (0.42) PDK1NPR3CYP3A4CYP2C8CYP2C9
SCHEMBL5906905 0.82 ADORA2A (0.42) PDK1NPR3CYP3A4CYP2C8CYP2C9
SCHEMBL5906688 0.78 MME (0.50) NPR3GPR142PPARGPPARAACE
SCHEMBL5906686 0.78 MME (0.50) NPR3GPR142PPARGPPARAACE
SCHEMBL5906830 0.76 NPR3 (0.52) NPR3CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL5906828 0.76 PPARG (0.54) PPARGPPARAACEITGA4
SCHEMBL5906832 0.76 PPARG (0.54) PPARGPPARAACEITGA4
SCHEMBL5906834 0.76 ADORA2A (0.41) PDK1NPR3CYP3A4CYP2C8CYP2C9
SCHEMBL5906838 0.76 ADORA2A (0.41) PDK1NPR3CYP3A4CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BAYER HEALTHCARE AG (DE) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BPHL, HRH4, HRH2 PDK1 1202/4885NPR3 444/4885CYP3A4 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.